AAAAAA

   
Results: 1-13 |
Results: 13
ENZYME ELECTRODE FOR GLUCOSE DETERMINATION IN WHOLE-BLOOD
Authors: SANTONI T SANTIANNI D MANZONI A ZANARDI S MASCINI M
Citation: T. Santoni et al., ENZYME ELECTRODE FOR GLUCOSE DETERMINATION IN WHOLE-BLOOD, Talanta, 44(9), 1997, pp. 1573-1580
FREQUENCY OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN ANTICOAGULANT FACTOR-DEFICIENT WOMEN - IMPLICATIONS FOR PROPHYLAXIS (VOL 125, PG 955, 1996)
Authors: FRIEDERICH PW SANSON BJ SIMIONI P ZANARDI S HUISMAN MV KINDT I
Citation: Pw. Friederich et al., FREQUENCY OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN ANTICOAGULANT FACTOR-DEFICIENT WOMEN - IMPLICATIONS FOR PROPHYLAXIS (VOL 125, PG 955, 1996), Annals of internal medicine, 127(12), 1997, pp. 1138-1138
FREQUENCY OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN ANTICOAGULANT FACTOR-DEFICIENT WOMEN - IMPLICATIONS FOR PROPHYLAXIS (VOL 125, PG 955, 1996)
Authors: FRIEDERICH PW SANSON BJ SIMIONI P ZANARDI S HUISMAN MV KINDT I
Citation: Pw. Friederich et al., FREQUENCY OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN ANTICOAGULANT FACTOR-DEFICIENT WOMEN - IMPLICATIONS FOR PROPHYLAXIS (VOL 125, PG 955, 1996), Annals of internal medicine, 126(10), 1997, pp. 835-835
THROMBOEMBOLIC DISEASE DEVELOPING DURING ORAL-CONTRACEPTIVE THERAPY IN YOUNG FEMALES WITH ANTIPHOSPHOLIPID ANTIBODIES
Authors: GIROLAMI A ZANON E ZANARDI S SARACINO MA SIMIONI P
Citation: A. Girolami et al., THROMBOEMBOLIC DISEASE DEVELOPING DURING ORAL-CONTRACEPTIVE THERAPY IN YOUNG FEMALES WITH ANTIPHOSPHOLIPID ANTIBODIES, Blood coagulation & fibrinolysis, 7(4), 1996, pp. 497-501
THE RISK OF ABORTION AND STILLBIRTH IN ANTITHROMBIN-DEFICIENT, PROTEIN C-DEFICIENT, AND PROTEIN S-DEFICIENT WOMEN
Authors: SANSON BJ FRIEDERICH PW SIMIONI P ZANARDI S HUISMAN MV GIROLAMI A TENCATE JW PRINS MH
Citation: Bj. Sanson et al., THE RISK OF ABORTION AND STILLBIRTH IN ANTITHROMBIN-DEFICIENT, PROTEIN C-DEFICIENT, AND PROTEIN S-DEFICIENT WOMEN, Thrombosis and haemostasis, 75(3), 1996, pp. 387-388
FREQUENCY OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN ANTICOAGULANT FACTOR-DEFICIENT WOMEN - IMPLICATIONS FOR PROPHYLAXIS
Authors: FRIEDERICH PW SANSON BJ SIMIONI P ZANARDI S HUISMAN MV KINDT I PRANDONI P BULLER HR GIROLAMI A PRINS MH
Citation: Pw. Friederich et al., FREQUENCY OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN ANTICOAGULANT FACTOR-DEFICIENT WOMEN - IMPLICATIONS FOR PROPHYLAXIS, Annals of internal medicine, 125(12), 1996, pp. 955
PATIENTS WITH APC RESISTANCE COMPARED WITH THOSE WITH OTHER CLOTTING INHIBITOR DEFICIENCIES SHOW LATER ONSET OF VENOUS THROMBOSIS DURING ORAL CONTRACEPTION
Authors: GIROLAMI A SIMIONI P ZANARDI S SCARANO L GIROLAMI B
Citation: A. Girolami et al., PATIENTS WITH APC RESISTANCE COMPARED WITH THOSE WITH OTHER CLOTTING INHIBITOR DEFICIENCIES SHOW LATER ONSET OF VENOUS THROMBOSIS DURING ORAL CONTRACEPTION, Clinical and applied thrombosis/hemostasis, 1(4), 1995, pp. 274-276
THE INCIDENCE OF VENOUS THROMBOEMBOLISM DURING PREGNANCY AND CHILDBIRTH AND THE INCIDENCE OF MISCARRIAGES IN ATIII-S-DEFICIENT, PROTEIN S-DEFICIENT, AND PROTEIN C-DEFICIENT WOMEN
Authors: ZANARDI S SANSON BJ GAVASSO S FRIEDERICH PW MARCHIORI A KINDT I PRANDONI P HUISMAN MV GIROLAMI A SIMIONI P PRINS MH
Citation: S. Zanardi et al., THE INCIDENCE OF VENOUS THROMBOEMBOLISM DURING PREGNANCY AND CHILDBIRTH AND THE INCIDENCE OF MISCARRIAGES IN ATIII-S-DEFICIENT, PROTEIN S-DEFICIENT, AND PROTEIN C-DEFICIENT WOMEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1263-1263
HEREDITARY ACTIVATED PROTEIN-C RESISTANCE (FV LEIDEN MUTATION) - CLINICAL MANIFESTATIONS
Authors: GIROLAMI A SIMIONI P ZANARDI S SARACINO MA GIROLAMI B ROSSI L GAVASSO S ZANON E
Citation: A. Girolami et al., HEREDITARY ACTIVATED PROTEIN-C RESISTANCE (FV LEIDEN MUTATION) - CLINICAL MANIFESTATIONS, Thrombosis and haemostasis, 73(6), 1995, pp. 1369-1369
EPIDERMAL GROWTH-FACTOR CONTENT OF BREAST CYST FLUIDS FROM WOMEN WITHBREAST-CANCER OR PROLIFERATIVE DISEASE OF THE BREAST
Authors: TORRISI R ZANARDI S PENSA F VALENTI G DEFRANCHIS V NICOLO G BARRECA A MINUTO F BOCCARDO F
Citation: R. Torrisi et al., EPIDERMAL GROWTH-FACTOR CONTENT OF BREAST CYST FLUIDS FROM WOMEN WITHBREAST-CANCER OR PROLIFERATIVE DISEASE OF THE BREAST, Breast cancer research and treatment, 33(3), 1995, pp. 219-224
PROLONGED ORAL-CONTRACEPTIVE THERAPY IN A WOMAN WITH AN ANTITHROMBIN-III ABNORMALITY INVOLVING HEPARIN-BINDING (TYPE-IIC) WITHOUT THROMBOEMBOLIC COMPLICATIONS
Authors: GIROLAMI A ZANARDI S SIMIONI P TORMENE D
Citation: A. Girolami et al., PROLONGED ORAL-CONTRACEPTIVE THERAPY IN A WOMAN WITH AN ANTITHROMBIN-III ABNORMALITY INVOLVING HEPARIN-BINDING (TYPE-IIC) WITHOUT THROMBOEMBOLIC COMPLICATIONS, Blood coagulation & fibrinolysis, 5(2), 1994, pp. 313-314
PRESENCE OF IMMUNOASSAYABLE TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) IN BREAST CYST FLUID (BCF) - RELATIONSHIP WITH THE INTRACYSTIC ELECTROLYTE AND EPIDERMAL-GROWTH-FACTOR (EGF) CONTENT
Authors: ZANARDI S PENSA F TORRISI R DEFRANCHIS V BARRECA A MINUTO F BOCCARDO F
Citation: S. Zanardi et al., PRESENCE OF IMMUNOASSAYABLE TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) IN BREAST CYST FLUID (BCF) - RELATIONSHIP WITH THE INTRACYSTIC ELECTROLYTE AND EPIDERMAL-GROWTH-FACTOR (EGF) CONTENT, International journal of cancer, 59(6), 1994, pp. 725-727
ARE ORAL-CONTRACEPTIVES A MORE IMPORTANT RISK FACTOR THAN PREGNANCY IN WOMEN WITH CONGENITAL ANTITHROMBIN-III DEFICIENCY
Authors: GIROLAMI A ZANARDI S SIMIONI P POLISTENA P VILLALTA S
Citation: A. Girolami et al., ARE ORAL-CONTRACEPTIVES A MORE IMPORTANT RISK FACTOR THAN PREGNANCY IN WOMEN WITH CONGENITAL ANTITHROMBIN-III DEFICIENCY, Blood coagulation & fibrinolysis, 4(5), 1993, pp. 841-842
Risultati: 1-13 |